Lv21
200 积分 2024-11-26 加入
Single-cell profiling of immune reset in patients with refractory generalized myasthenia gravis receiving autologous CD19/BCMA CAR-T cell therapy
2小时前
待确认
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
21天前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
3个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
3个月前
已完结
Glial injury in neurotoxicity after pediatric CD19‐directed chimeric antigen receptor T cell therapy
3个月前
已完结
Integrating multiple sclerosis guidelines into practice
3个月前
已完结
AAN unveils new guidelines for MS disease-modifying therapy
3个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
3个月前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
4个月前
已完结
Developing cell therapies for lupus
4个月前
已完结
皖公网安备34019202002308
